STOCK PURCHASE AND SETTLEMENT AGREEMENTStock Purchase and Settlement Agreement • August 3rd, 2018 • Morris Ryan J. • Surgical & medical instruments & apparatus • Delaware
This Stock Purchase and Settlement Agreement (this “Agreement”) is dated as of July 31, 2018, and entered into among InfuSystem Holdings, Inc. (the “Company”), Ryan J. Morris, an individual, and Meson Capital, L.P., a Delaware limited partnership (collectively, the “Sellers”) (each of the Company and the Sellers, a “Party” to this Agreement, and collectively, the “Parties”).
JOINT FILING AND SOLICITATION AGREEMENTJoint Filing and Solicitation Agreement • May 11th, 2018 • Morris Ryan J. • Surgical & medical instruments & apparatus
WHEREAS, certain of the undersigned are stockholders, direct or beneficial, of InfuSystem Holdings, Inc., a Delaware corporation (the “Company”);
JOINT FILING AGREEMENTJoint Filing Agreement • July 23rd, 2018 • Morris Ryan J. • Surgical & medical instruments & apparatus
In accordance with Rule 13d-1(k)(iii) under the Securities Exchange Act of 1934, as amended, persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Common Stock, par value $0.0001 per share, of InfuSystem Holdings, Inc., a Delaware corporation, and further agree that this Joint Filing Agreement shall be filed as an Exhibit to such Statement.
JOINT FILING AND SOLICITATION AGREEMENTJoint Filing and Solicitation Agreement • April 25th, 2018 • Morris Ryan J. • Surgical & medical instruments & apparatus
WHEREAS, certain of the undersigned are stockholders, direct or beneficial, of InfuSystem Holdings, Inc., a Delaware corporation (the “Company”);
JOINT FILING AGREEMENTJoint Filing Agreement • March 21st, 2018 • Morris Ryan J. • Surgical & medical instruments & apparatus
In accordance with Rule 13d-1(k)(iii) under the Securities Exchange Act of 1934, as amended, persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Common Stock, par value $0.0001 per share, of InfuSystems Holdings, Inc., a Delaware corporation, and further agree that this Joint Filing Agreement shall be filed as an Exhibit to such Statement.
